hLSm4 is a component of the heptameric LSm complex involved in mRNA processing. Autoantibodies against hLSm4 have been identified in systemic lupus erythematosus (SLE) patients:
| Parameter | Data from SLE Studies ( ) |
|---|---|
| Prevalence in anti-Sm SLE | ~80% recognize recombinant hLSm4 |
| Exclusive LSm reactivity | 0.92% (4/434 sera) |
| Associated complexes | Co-precipitates with U4/U6 snRNP |
Structural role: hLSm4 forms part of mRNA decapping/degradation complexes.
Clinical relevance: Anti-hLSm4 antibodies correlate with SLE but are distinct from classical anti-Sm antibodies targeting Sm core proteins.
SYT4 is a calcium sensor involved in membrane trafficking. The monoclonal antibody 5F8 targets SYT4:
| Parameter | Data ( ) |
|---|---|
| Applications | Western blot, ICC/IF, ELISA |
| Detection limit (ELISA) | 0.03 ng/ml for recombinant SYT4 |
| Reactivity | Human SYT4 (UniProt ID Q9H8B7) |
Functional insights: SYT4 regulates neurosecretory pathways and insulin exocytosis.
Experimental utility: Used to study SYT4 localization in neuronal and endocrine cells.
The term "SHM4" may originate from:
No peer-reviewed studies explicitly define "SHM4 Antibody" as a standalone entity.
Prioritize validation of target specificity in future studies.
Clarify whether the term refers to: